Navigation Links
LaVoie Group Adds Interleukin Genetics to its Life Science Agency Roster
Date:4/14/2008

SALEM, Mass., April 14 /PRNewswire/ -- LaVoie Group, a full-service provider of public relations, investor relations, corporate communications, and marketing strategy to life science clients, today announced that it has been selected as public relations agency of record by Interleukin Genetics (Amex: ILI).

Donna L. LaVoie, President & CEO, commented, "With personalized medicine top of mind across a number of different constituencies, Interleukin Genetics is well positioned to capitalize on its strengths in genetics research to develop a series of innovative preventive products. LaVoie Group looks forward to continue helping Interleukin communicate its story."

About Interleukin

Interleukin Genetics, Inc. (Amex: ILI) is a genetics-focused personalized health company that develops preventive consumer products and genetic tests for sale to the emerging personalized health market. Focused on the future of health and medicine, Interleukin uses its leading genetics research and scientific capabilities to develop and test innovative preventive and therapeutic products. Interleukin currently offers an array of Nutraceuticals and OTCeuticals(R), including Ginkoba(R), Ginsana(R) and Venastat(R) which are sold at the nation's largest food, drug and mass retailers, and has commercialized genetic tests for periodontal disease risk assessment, cardiovascular risk assessment, and general nutrition assessment. Interleukin is headquartered in Waltham, MA. For more information about Interleukin and its ongoing programs, please visit http://www.ilgenetics.com.

About LaVoie Group

LaVoie Group provides senior level strategic counsel and tactical implementation of public, investor and corporate communications programs designed to properly position create visibility and drive value for each client. Our clients range from private start-ups to industry leaders in life sciences. For more information, please visit http://www.lavoiegroup.com.


'/>"/>
SOURCE LaVoie Group
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. LaVoie Group Adds Two New Companies to Its Life Science Client Roster
2. Broad-based group of physicians calls for improvement in stroke treatment
3. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
4. CIGNA Group Insurance Shows Consumers Theres More to Life Through a New Consumer Education Toolkit
5. HIDA Calls for Scrutiny of Group Purchasing Organization Distributor Fee Structure
6. New Research Uncovers how to Build and Maintain an Effective Competitive Intelligence Group
7. AMERIGROUP to Acquire Memphis Health Plan
8. Securians Minnesota Life Continues to Climb Group Life Rankings
9. Dr. Allen Woolf Appointed Chief Medical Officer For CIGNA Group Insurance
10. Are Bargaining Groups Hired by Independent Drugstores Causing Payment Delays to Pharmacies?
11. Group B Strep: A Threat to Newborns That Doesnt Have to Be
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2017)... ... April 24, 2017 , ... The bar for just about everything—apparel, eyewear, cars ... rarified air of pop and film stardom.(1) Not to be left out is that ... Grins now run the gamut from being encrusted with jewels and precious metals to, ...
(Date:4/24/2017)... Chicago, Illinois (PRWEB) , ... April 24, 2017 , ... ... home. What happened next changed her life forever. , In “Healing Tears,” James depicts ... “At the advice of my attorney, I began journaling conversations and situations throughout my ...
(Date:4/24/2017)... Raton, Florida (PRWEB) , ... April 24, 2017 , ... ... chai teas, announced its products are now available for purchase on RevNutrition.com, a popular ... form of tea first produced and popularized in ancient India and Siam. It spread ...
(Date:4/24/2017)... CA (PRWEB) , ... April 24, 2017 , ... ... brain tumors are expected to be diagnosed globally; approximately 25,000 of them will ... are anticipating greater use of this type of healthcare model in the diagnosis ...
(Date:4/24/2017)... CA (PRWEB) , ... April 24, 2017 , ... As ... is worth a thousand words. The good news for single women is that she ... Attraction," which is available on April 25th. Joan's insight, personal experiences and sparkling sense ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... -- AbbVie (NYSE: ABBV), a global biopharmaceutical company, today ... C virus (HCV) infected patients with genotype 1, ... (Child-Pugh A) achieved sustained virologic response at 12 ... pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). These high SVR ... of G/P treatment without ribavirin. Patients with specific ...
(Date:4/19/2017)... - CRH Medical Corporation (TSX: CRH) (NYSE MKT: CRHM) (the "Company"), announces that ... Conference 2017 at the Sheraton Hotel in Toronto, Ontario ... of the Company is scheduled to present on Tuesday, May 2 ... the Chairman of the Board, Tony Holler will also ... For more ...
(Date:4/19/2017)... April 19, 2017 Global Prostate Cancer ... on the prostate cancer therapeutics market analyzes the ... Increasing prevalence of prostate cancer, launch of promising ... development of new drugs & therapeutic biological products, ... due to lesser side effects are some of ...
Breaking Medicine Technology: